NYSE:RAD - Rite Aid Stock Price, Price Target & More

$1.62 +0.07 (+4.52 %)
(As of 04/25/2018 06:24 AM ET)
Previous Close$1.55
Today's Range$1.54 - $1.64
52-Week Range$1.38 - $4.28
Volume10.08 million shs
Average Volume24.74 million shs
Market Capitalization$1.65 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.8

About Rite Aid (NYSE:RAD)

Rite Aid logoRite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through Retail Pharmacy and Pharmacy Services segments. The Retail Pharmacy segment sells prescription drugs; and a range of other merchandise, such as over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products. This segment also operates retail clinics that provide treatment for common conditions; and a range of preventive services, including screenings, medical tests, immunizations, and basic physical exams. In addition, this segment provides healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; offers integrated mail-order and specialty and compounding pharmacy services; and provides infertility treatment, as well as drug benefits under the federal government's Medicare Part D program. As of June 20, 2017, the company operated approximately 4,500 stores in 31 states of the United States and in the District of Columbia. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.

Receive RAD News and Ratings via Email

Sign-up to receive the latest news and ratings for RAD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
SymbolNYSE:RAD
CUSIP76775410
Phone717-761-2633

Debt

Debt-to-Equity Ratio2.11%
Current Ratio1.37%
Quick Ratio0.85%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$21.53 billion
Price / Sales0.08
Cash Flow$0.3279 per share
Price / Cash4.94
Book Value$1.50 per share
Price / Book1.08

Profitability

EPS (Most Recent Fiscal Year)($0.02)
Net Income$943.47 million
Net Margins3.60%
Return on Equity-8.25%
Return on Assets-0.71%

Miscellaneous

Employees87,000
Outstanding Shares1,067,650,000

How to Become a New Pot Stock Millionaire

Rite Aid (NYSE:RAD) Frequently Asked Questions

What is Rite Aid's stock symbol?

Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."

How were Rite Aid's earnings last quarter?

Rite Aid (NYSE:RAD) announced its quarterly earnings data on Thursday, April, 12th. The company reported ($0.01) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.02) by $0.01. The business had revenue of $5.39 billion for the quarter, compared to analyst estimates of $5.75 billion. Rite Aid had a net margin of 3.60% and a negative return on equity of 8.25%. Rite Aid's revenue was down 8.6% on a year-over-year basis. View Rite Aid's Earnings History.

When is Rite Aid's next earnings date?

Rite Aid is scheduled to release their next quarterly earnings announcement on Thursday, July, 5th 2018. View Earnings Estimates for Rite Aid.

What guidance has Rite Aid issued on next quarter's earnings?

Rite Aid updated its FY19 earnings guidance on Thursday, April, 12th. The company provided earnings per share (EPS) guidance of $0.02-0.06 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.03. The company issued revenue guidance of $21.7-22.1 billion, compared to the consensus revenue estimate of $21.73 billion.

What price target have analysts set for RAD?

8 brokers have issued 1-year price targets for Rite Aid's stock. Their forecasts range from $1.50 to $4.70. On average, they expect Rite Aid's stock price to reach $2.3063 in the next year. View Analyst Ratings for Rite Aid.

Are investors shorting Rite Aid?

Rite Aid saw a drop in short interest in the month of April. As of April 13th, there was short interest totalling 147,325,348 shares, a drop of 10.2% from the March 30th total of 163,994,755 shares. Based on an average daily volume of 13,746,623 shares, the short-interest ratio is currently 10.7 days. Approximately 13.9% of the shares of the company are short sold.

Who are some of Rite Aid's key competitors?

Who are Rite Aid's key executives?

Rite Aid's management team includes the folowing people:
  • Mr. John T. Standley, Chairman & CEO (Age 55)
  • Mr. Darren W. Karst, Sr. Exec. VP, CFO & Chief Admin. Officer (Age 58)
  • Mr. Bryan Everett, Chief Operating Officer of Rite Aid Stores (Age 45)
  • Mr. Kermit R. Crawford, Pres & COO (Age 59)
  • Mr. Douglas Elwood Donley, Sr. VP & Chief Accounting Officer (Age 56)

Has Rite Aid been receiving favorable news coverage?

Media coverage about RAD stock has been trending somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Rite Aid earned a news impact score of 0.12 on Accern's scale. They also gave media coverage about the company an impact score of 47.61 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Rite Aid?

Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Rite Aid's stock price today?

One share of RAD stock can currently be purchased for approximately $1.62.

How big of a company is Rite Aid?

Rite Aid has a market capitalization of $1.69 billion and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 87,000 workers across the globe.

How can I contact Rite Aid?

Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17105. The company can be reached via phone at 717-761-2633 or via email at [email protected]


MarketBeat Community Rating for Rite Aid (RAD)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  375 (Vote Outperform)
Underperform Votes:  372 (Vote Underperform)
Total Votes:  747
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Rite Aid (NYSE:RAD) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
8 Wall Street analysts have issued ratings and price targets for Rite Aid in the last 12 months. Their average twelve-month price target is $2.3063, suggesting that the stock has a possible upside of 42.36%. The high price target for RAD is $4.70 and the low price target for RAD is $1.50. There are currently 2 sell ratings, 5 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.881.882.002.00
Ratings Breakdown: 2 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.3063$2.3063$2.7722$3.3556
Price Target Upside: 42.36% upside10.88% upside33.28% upside88.51% upside

Rite Aid (NYSE:RAD) Consensus Price Target History

Price Target History for Rite Aid (NYSE:RAD)

Rite Aid (NYSE:RAD) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/17/2018MizuhoReiterated RatingHoldMediumView Rating Details
1/4/2018Evercore ISIInitiated CoverageUnderperform -> Underperform$1.50MediumView Rating Details
12/4/2017Deutsche BankInitiated CoverageHold$2.25MediumView Rating Details
10/25/2017Royal Bank of CanadaSet Price TargetHold$2.00N/AView Rating Details
10/2/2017GuggenheimReiterated RatingNeutral$2.00LowView Rating Details
9/29/2017Loop CapitalReiterated RatingHold -> Hold$2.50 -> $2.00HighView Rating Details
7/3/2017CowenReiterated RatingOutperform$4.70HighView Rating Details
6/30/2017Bank of AmericaReiterated RatingUnderperform$2.00HighView Rating Details
3/20/2017Credit Suisse GroupReiterated RatingOutperform$6.50LowView Rating Details
6/17/2016JPMorgan ChaseReiterated RatingHoldN/AView Rating Details
(Data available from 4/25/2016 forward)

Earnings

Rite Aid (NYSE:RAD) Earnings History and Estimates Chart

Earnings by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE:RAD) Earnings Estimates

2018 EPS Consensus Estimate: $0.22
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.03$0.03$0.03
Q2 20181$0.04$0.04$0.04
Q3 20181$0.08$0.08$0.08
Q4 20181$0.07$0.07$0.07

Rite Aid (NYSE RAD) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/5/2018        
4/12/2018Q4 2018($0.02)($0.01)$5.7519 billion$5.3943 billionViewListenView Earnings Details
9/28/2017Q2 2018($0.01)($0.01)$7.8286 billion$7.6789 billionViewN/AView Earnings Details
6/29/2017Q1 2018($0.0130)($0.05)$8.2902 billion$7.7815 billionViewN/AView Earnings Details
12/22/2016Q317$0.04$0.02$8.2296 billion$8.0897 billionViewN/AView Earnings Details
9/22/2016Q2$0.03$0.03$8.0860 billion$8.0298 billionViewN/AView Earnings Details
6/16/2016Q117$0.05$0.01$8.2312 billion$8.1842 billionViewN/AView Earnings Details
4/7/2016Q416$0.06$0.07$8.4680 billion$8.2701 billionViewN/AView Earnings Details
12/17/2015Q316$0.06$0.06$8.2016 billion$8.1542 billionViewN/AView Earnings Details
9/17/2015Q216$0.03$0.02$7.6014 billion$7.6648 billionViewListenView Earnings Details
6/18/2015Q116$0.03$0.04$6.65 billion$6.60 billionViewListenView Earnings Details
4/8/2015Q415$0.07$0.12$6.7887 billion$6.85 billionViewN/AView Earnings Details
12/18/2014Q315$0.05$0.10$6.55 billion$6.70 billionViewListenView Earnings Details
9/18/2014Q215$0.06$0.13$6.4920 billion$6.5226 billionViewListenView Earnings Details
6/19/2014Q115$0.05$0.04$6.43 billion$6.47 billionViewListenView Earnings Details
4/10/2014Q414$0.04$0.10$6.54 billion$6.60 billionViewListenView Earnings Details
12/19/2013Q314$0.04$0.04$6.30 billion$6.36 billionViewListenView Earnings Details
9/19/2013Q2 2014($0.04)$0.03$6.27 billion$6.30 billionViewListenView Earnings Details
6/20/2013Q1 2014$0.09$0.09$6.27 billion$6.30 billionViewListenView Earnings Details
4/11/2013Q4 2013($0.02)$0.13$6.47 billion$6.50 billionViewListenView Earnings Details
12/20/2012Q3 2013($0.03)$0.07$6.28 billion$6.24 billionViewListenView Earnings Details
9/20/2012Q213($0.07)($0.05)$6.20 billion$6.20 billionViewN/AView Earnings Details
6/21/2012($0.03)($0.03)ViewN/AView Earnings Details
4/12/2012($0.17)($0.18)ViewN/AView Earnings Details
12/15/2011($0.13)($0.06)ViewN/AView Earnings Details
9/22/2011($0.17)($0.11)ViewN/AView Earnings Details
6/23/2011($0.12)($0.07)ViewN/AView Earnings Details
4/7/2011($0.24)($0.24)ViewN/AView Earnings Details
12/16/2010($0.13)($0.09)$6.1981 billion$6.2020 billionViewN/AView Earnings Details
9/23/2010Q2 2011($0.16)($0.18)ViewN/AView Earnings Details
6/23/2010Q1 2011($0.14)($0.09)ViewN/AView Earnings Details
3/31/2010Q4 2010($0.19)($0.24)ViewN/AView Earnings Details
12/17/2009Q3 2010($0.18)($0.10)ViewN/AView Earnings Details
9/24/2009Q2 2010($0.15)($0.14)ViewN/AView Earnings Details
6/24/2009Q1 2010($0.13)($0.11)ViewN/AView Earnings Details
4/2/2009Q4 2009($0.11)($0.14)ViewN/AView Earnings Details
12/18/2008Q3 2009($0.17)($0.17)ViewN/AView Earnings Details
9/25/2008Q2 2009($0.14)($0.27)ViewN/AView Earnings Details
6/26/2008Q1 2009($0.09)($0.20)ViewN/AView Earnings Details
4/10/2008Q4 2008($0.07)($0.07)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Rite Aid (NYSE:RAD) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Rite Aid (NYSE RAD) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.29%
Institutional Ownership Percentage: 47.47%
Insider Trading History for Rite Aid (NYSE:RAD)
Institutional Ownership by Quarter for Rite Aid (NYSE:RAD)

Rite Aid (NYSE RAD) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/3/2017Myrtle S PotterDirectorSell28,189$2.09$58,915.01View SEC Filing  
6/15/2016Douglas E DonleySVPSell34,106$7.77$265,003.6282,885View SEC Filing  
7/9/2015Tony MontiniEVPSell353,194$8.38$2,959,765.72View SEC Filing  
4/15/2015Joseph B Anderson JrDirectorSell150,000$8.25$1,237,500.00View SEC Filing  
4/13/2015Robert K ThompsonEVPSell95,850$8.33$798,430.50View SEC Filing  
4/10/2015Douglas E DonleyCAOSell59,404$8.21$487,706.84View SEC Filing  
4/10/2015Marcy SymsDirectorSell150,000$8.26$1,239,000.00View SEC Filing  
12/29/2014Tony MontiniEVPSell49,525$7.47$369,951.75View SEC Filing  
12/23/2014Tony MontiniEVPSell259,750$6.92$1,797,470.00View SEC Filing  
12/22/2014John T StandleyCEOSell1,700,000$6.82$11,594,000.00View SEC Filing  
12/22/2014Kenneth MartindaleCOOSell1,043,400$6.80$7,095,120.00View SEC Filing  
12/22/2014Robert Ivan ThompsonEVPSell149,231$6.80$1,014,770.80View SEC Filing  
7/3/2014Robert Ivan ThompsonEVPSell249,583$7.48$1,866,880.84View SEC Filing  
6/24/2014Joseph B Anderson JrDirectorSell26,667$7.05$188,002.35View SEC Filing  
6/23/2014Robert Ivan ThompsonEVPSell510,000$7.06$3,600,600.00View SEC Filing  
4/22/2014Marc StrasslerEVPSell224,800$7.12$1,600,576.00699,369View SEC Filing  
4/21/2014Frank VitranoEVPSell1,913,925$7.08$13,550,589.001,183,384View SEC Filing  
4/16/2014Robert Ivan ThompsonEVPSell25,566$7.03$179,728.98749,882View SEC Filing  
2/19/2014John StandleyCEOSell1,200,000$6.23$7,476,000.002,974,958View SEC Filing  
2/19/2014Kenneth MartindaleCOOSell666,667$6.23$4,153,335.411,193,252View SEC Filing  
1/21/2014Douglas DonleySVPSell24,173$5.79$139,961.6781,628View SEC Filing  
1/3/2014John StandleyCEOSell600,000$5.48$3,288,000.002,974,958View SEC Filing  
1/3/2014Kenneth MartindaleCOOSell333,333$5.48$1,826,664.841,193,252View SEC Filing  
10/18/2013Robert K ThompsonEVPSell250,000$5.27$1,317,500.00View SEC Filing  
10/17/2013Douglas E DonleySVPSell88,700$5.27$467,449.00View SEC Filing  
10/17/2013Marc A StrasslerEVPSell100,000$5.31$531,000.00View SEC Filing  
10/14/2013Frank VitranoCFOSell1,982,900$5.00$9,914,500.001,183,384View SEC Filing  
10/4/2013Tony MontiniEVPSell414,500$5.21$2,159,545.00643,713View SEC Filing  
9/25/2013Robert Ivan ThompsonEVPSell400,000$4.81$1,924,000.00749,882View SEC Filing  
7/18/2013Robert K ThompsonEVPSell401,655$3.01$1,208,981.55View SEC Filing  
7/16/2013David JessickInsiderSell100,000$2.93$293,000.00View SEC Filing  
7/16/2013Marc A StrasslerEVPSell375,000$2.96$1,110,000.00View SEC Filing  
7/12/2013Douglas E DonleySVPSell6,899$2.80$19,317.20View SEC Filing  
7/11/2013Douglas E DonleySVPSell75,378$2.78$209,550.84View SEC Filing  
7/11/2013Robert Ivan ThompsonEVPSell375,000$2.75$1,031,250.00View SEC Filing  
6/26/2013Jean Coutu Group (Pjc) Inc.Major ShareholderSell40,500,000$2.75$111,375,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Rite Aid (NYSE RAD) News Headlines

Source:
DateHeadline
Critical Comparison: Rite Aid (RAD) vs. Express Scripts (ESRX)Critical Comparison: Rite Aid (RAD) vs. Express Scripts (ESRX)
www.americanbankingnews.com - April 24 at 3:32 PM
$5.35 Billion in Sales Expected for Rite Aid (RAD) This Quarter$5.35 Billion in Sales Expected for Rite Aid (RAD) This Quarter
www.americanbankingnews.com - April 23 at 2:46 AM
Contrasting Rite Aid (RAD) and Express Scripts (ESRX)Contrasting Rite Aid (RAD) and Express Scripts (ESRX)
www.americanbankingnews.com - April 21 at 5:14 PM
Naloxone available at Rite-Aid without prescriptionNaloxone available at Rite-Aid without prescription
finance.yahoo.com - April 20 at 3:11 PM
Rite Aids Merger Still Makes SenseRite Aid's Merger Still Makes Sense
seekingalpha.com - April 19 at 3:12 PM
Naloxone Available at Rite Aid Pharmacies in 19 StatesNaloxone Available at Rite Aid Pharmacies in 19 States
finance.yahoo.com - April 19 at 3:12 PM
Rite Aid (RAD) Given Average Recommendation of "Hold" by BrokeragesRite Aid (RAD) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 18 at 5:30 PM
Albertsons Companies, LLC -- Moodys assigns B1 CFR to Albertsons Companies, Inc.; outlook negativeAlbertsons Companies, LLC -- Moody's assigns B1 CFR to Albertsons Companies, Inc.; outlook negative
finance.yahoo.com - April 18 at 3:11 PM
A Look at Rite Aid’s Fiscal 2019 GuidanceA Look at Rite Aid’s Fiscal 2019 Guidance
finance.yahoo.com - April 18 at 3:11 PM
Mizuho Reiterates Hold Rating for Rite Aid (RAD)Mizuho Reiterates Hold Rating for Rite Aid (RAD)
www.americanbankingnews.com - April 18 at 8:42 AM
What Drove Down Rite Aid’s Fiscal 4Q18 Sales?What Drove Down Rite Aid’s Fiscal 4Q18 Sales?
finance.yahoo.com - April 17 at 3:15 PM
After Shareholder Backlash, Rite Aid-Albertsons Deal May Get RenegotiatedAfter Shareholder Backlash, Rite Aid-Albertsons Deal May Get Renegotiated
seekingalpha.com - April 16 at 5:57 AM
Short Interest in Rite Aid (RAD) Increases By 11.9%Short Interest in Rite Aid (RAD) Increases By 11.9%
www.americanbankingnews.com - April 15 at 1:34 AM
Rite Aid (RAD) Reports Narrower-Than-Estimated Loss in Q4Rite Aid (RAD) Reports Narrower-Than-Estimated Loss in Q4
www.zacks.com - April 13 at 3:15 PM
Rite Aid: Good News OverlookedRite Aid: Good News Overlooked
seekingalpha.com - April 13 at 3:15 PM
Rite Aid (RAD) Q4 2018 Earnings Conference Call TranscriptRite Aid (RAD) Q4 2018 Earnings Conference Call Transcript
finance.yahoo.com - April 13 at 3:15 PM
Zacks Investment Research Lowers Rite Aid (RAD) to HoldZacks Investment Research Lowers Rite Aid (RAD) to Hold
www.americanbankingnews.com - April 13 at 11:45 AM
Rite Aids (RAD) CEO John Standley on Q4 2018 Results - Earnings Call TranscriptRite Aid's (RAD) CEO John Standley on Q4 2018 Results - Earnings Call Transcript
seekingalpha.com - April 13 at 5:21 AM
Rite Aid Shareholders Sour on Albertsons DealRite Aid Shareholders Sour on Albertsons Deal
finance.yahoo.com - April 13 at 5:21 AM
Rite Aid up 2% on Q4 results; provides guidanceRite Aid up 2% on Q4 results; provides guidance
seekingalpha.com - April 12 at 3:10 PM
UPDATE: Rite Aid tops earnings estimates after completing sale of stores to WalgreensUPDATE: Rite Aid tops earnings estimates after completing sale of stores to Walgreens
www.marketwatch.com - April 12 at 3:10 PM
Rite Aid misses, UK says Disney must bid for Sky, Tesla’s Model Y to reportedly start production in 2019Rite Aid misses, UK says Disney must bid for Sky, Tesla’s Model Y to reportedly start production in 2019
finance.yahoo.com - April 12 at 3:10 PM
Drug retailer Rite Aids upbeat forecast lifts sharesDrug retailer Rite Aid's upbeat forecast lifts shares
www.reuters.com - April 12 at 3:10 PM
Rite Aid (RAD) Releases FY19 Earnings GuidanceRite Aid (RAD) Releases FY19 Earnings Guidance
www.americanbankingnews.com - April 12 at 8:55 AM
Rite Aid (RAD) Issues  Earnings Results, Beats Estimates By $0.01 EPSRite Aid (RAD) Issues Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - April 12 at 8:55 AM
Why Rite Aid Short Interest Continues to Climb Ahead of Merger With AlbertsonsWhy Rite Aid Short Interest Continues to Climb Ahead of Merger With Albertsons
www.msn.com - April 11 at 3:15 PM
Rite Aid Post MortemRite Aid Post Mortem
seekingalpha.com - April 10 at 5:17 AM
Albertsons Withdraws IPO Plan Due To Rite Aid Merger DealAlbertsons Withdraws IPO Plan Due To Rite Aid Merger Deal
www.nasdaq.com - April 6 at 3:15 PM
Rite Aid (RAD) Scheduled to Post Earnings on ThursdayRite Aid (RAD) Scheduled to Post Earnings on Thursday
www.americanbankingnews.com - April 5 at 1:08 AM
Rite Aid (RAD) Given a $2.00 Price Target by Royal Bank of Canada AnalystsRite Aid (RAD) Given a $2.00 Price Target by Royal Bank of Canada Analysts
www.americanbankingnews.com - April 4 at 9:36 PM
Albertsons Clears US Antitrust Hurdle in Acquisition of Drugstore Operator Rite AidAlbertsons Clears US Antitrust Hurdle in Acquisition of Drugstore Operator Rite Aid
www.bloomberg.com - April 3 at 3:09 PM
Rite Aid-Albertsons Merger Crosses First Antitrust HurdleRite Aid-Albertsons Merger Crosses First Antitrust Hurdle
www.zacks.com - April 2 at 3:14 PM
Rite Aid to Release Fourth Quarter Results on April 12Rite Aid to Release Fourth Quarter Results on April 12
finance.yahoo.com - April 2 at 3:14 PM
Kroger, Not Albertsons, Should Get Rite AidKroger, Not Albertsons, Should Get Rite Aid
seekingalpha.com - April 1 at 3:13 PM
Rite Aid Co. (RAD) Short Interest UpdateRite Aid Co. (RAD) Short Interest Update
www.americanbankingnews.com - March 31 at 3:18 AM
Rite Aid Announces Results of Offer to Purchase Certain of its Outstanding Series of NotesRite Aid Announces Results of Offer to Purchase Certain of its Outstanding Series of Notes
finance.yahoo.com - March 30 at 3:13 PM
LB-UBS Commercial Mortgage Trust 2006-C6 -- Moodys Affirms Five and Downgrades Two Classes of LBUBS 2006-C6LB-UBS Commercial Mortgage Trust 2006-C6 -- Moody's Affirms Five and Downgrades Two Classes of LBUBS 2006-C6
finance.yahoo.com - March 30 at 5:20 AM
Rite Aid - Albertsons Deal Gets U.S. Regulatory ApprovalRite Aid - Albertsons Deal Gets U.S. Regulatory Approval
www.rttnews.com - March 29 at 3:09 PM
Rite Aid Announces Expiration of Hart-Scott-Rodino Waiting Period for Merger with Albertsons CompaniesRite Aid Announces Expiration of Hart-Scott-Rodino Waiting Period for Merger with Albertsons Companies
finance.yahoo.com - March 29 at 3:09 PM
Walgreens: Top Line Grows 12% in Fiscal 2Q18Walgreens: Top Line Grows 12% in Fiscal 2Q18
finance.yahoo.com - March 29 at 3:09 PM
Rite Aid (RAD) Completes Agreed Store Transfers to WalgreensRite Aid (RAD) Completes Agreed Store Transfers to Walgreens
finance.yahoo.com - March 29 at 3:09 PM
Rite Aid-Albertsons Deal Clears Key U.S. Antitrust HurdleRite Aid-Albertsons Deal Clears Key U.S. Antitrust Hurdle
finance.yahoo.com - March 29 at 3:09 PM
ReadyCap Commercial Mortgage Trust 2014-1 -- Moodys Upgrades Three and Affirms Two Classes of RCCMT 2014-1ReadyCap Commercial Mortgage Trust 2014-1 -- Moody's Upgrades Three and Affirms Two Classes of RCCMT 2014-1
finance.yahoo.com - March 29 at 3:09 PM
LB Commercial Mortgage Trust 1999-C1 -- Moodys Upgrades One and Affirms Three Classes of LBCMT 1999-C1LB Commercial Mortgage Trust 1999-C1 -- Moody's Upgrades One and Affirms Three Classes of LBCMT 1999-C1
finance.yahoo.com - March 29 at 5:19 AM
Rite Aid (RAD) Completes Transfer of Stores to Walgreens Boots Alliance (WBA)Rite Aid (RAD) Completes Transfer of Stores to Walgreens Boots Alliance (WBA)
www.streetinsider.com - March 28 at 3:04 PM
Rite Aid (RAD) Upgraded to "Strong-Buy" at VetrRite Aid (RAD) Upgraded to "Strong-Buy" at Vetr
www.americanbankingnews.com - March 28 at 12:00 AM
Walgreens Struggles Despite Being a Healthcare HubWalgreens Struggles Despite Being a Healthcare Hub
finance.yahoo.com - March 27 at 3:17 PM
Rite Aid Co. (RAD) Receives Consensus Rating of "Hold" from AnalystsRite Aid Co. (RAD) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - March 24 at 5:40 PM
Will Rite Aid's (RAD) Soft Sales Hurt Earnings Again in Q4?Will Rite Aid's (RAD) Soft Sales Hurt Earnings Again in Q4?
finance.yahoo.com - March 22 at 3:21 PM
State AG partners with Penguins, Rite Aid foundations to launch prescription-drug safety programState AG partners with Penguins, Rite Aid foundations to launch prescription-drug safety program
www.cnbc.com - March 22 at 1:53 PM

SEC Filings

Rite Aid (NYSE:RAD) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Rite Aid (NYSE:RAD) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Rite Aid (NYSE RAD) Stock Chart for Wednesday, April, 25, 2018

Loading chart…

This page was last updated on 4/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.